Skip to main content

Table 1 Anthropometric, clinical, and laboratory data in the obese and control groups

From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children

 

Obese group (mean ± SD)

Control group (mean ± SD)

p value

Height (SDS)

0.467 ± 1.10

− 0.765 ± 0.577

0.042

Weight (SDS)

3.16 ± 1.52

− 0.0319 ± 0.594

0.000**

BMI (kg/m2)

29.87 ± 3.35

18.22 ± 1.87

0.000**

BMI (SDS)

3.123 ± 0.607

− 0.776 ± 0.789

0.000**

Waist circumference (cm)

88.38 ± 8.28

57.33 ± 4.76

0.000**

Hip circumference (cm)

94.08 ± 9.87

68.86 ± 7.33

0.000**

W/H ratio

0.938 ± 0.053

0.830 ± 0.047

0.000**

Biceps skin fold (SDS)

1.9 ± 1.72

1.15 ± 1.2

0.000**

Triceps skin fold (SDS)

2 ± 1.77

0.80 ± 1.08

0.000**

Subscapular skin fold (SDS)

3 ± 4.96

0.9 1 ± 1.06

0.000**

Systolic Bp (mmHg)

115.28 ± 9.06

101.40 ± 6.38

0.000**

Diastolic Bp (mmHg)

77.79 ± 11.56

63.79 ± 5.97

0.000**

Total cholesterol (mg/dl)

168.40 ± 28.44

144.17 ± 25.97

0. 000

Triglycerides (mg/dl)

100.51 ± 29.67

57.60 ± 15.02

0.000

HDL-c (mg/dl)

41.23 ± 10.87

43.191 ± 11.037

0.412

LDL-c (mg/dl)

103.05 ± 32.39

89.74 ± 20.74

0.027

FBS (mg/dl)

94.37 ± 9.51

87.69 ± 9.94

0.001

Insulin (μIU/ml)

17.75 ± 8.067

7.78 ± 2.58

0.000

HOMA-IR

4.14 ± 1.94

1.67 ± 0.609

0.000

PAI-1 (ng/dl)

47.98 ± 17.42

28.00 ± 11.35

0.000

  1. W/H waist/hip ratio, BMI body mass index, SDS standard deviation score, Bp blood pressure
  2. **p value highly significant < 0.01